Our TB-500 monograph covers its pharmacology in more detail
Glycine: In a randomized controlled trial in OCD patients, very high-dose glycine or placebo was added to ongoing pharmaceutical or behavioral therapy
sALS and fALS share several features, including protein aggregation, motor neuron hyperexcitability, trafficking defects, disruption of nucleocytoplasmic transport, oxidative stress, mitochondrial dysfunction, glutamate excitotoxicity, and neuroinflammation
Common side effects include: Nausea and vomiting Diarrhoea or constipation Reduced appetite (which is also a therapeutic effect) Injection site reactions (redness, bruising, or mild discomfort) These effects are typically mild to moderate and tend to resolve as the body adjusts to the medication
(Endocrinology, 2001) demonstrated in obese rodent models that AOD-9604 stimulated fat breakdown and inhibited lipogenesis without producing measurable changes in IGF-1 concentrations or causing the glucose intolerance associated with full-length GH administration [6]
The important result comes from studies that compare two drugs together: taking Cagrilintide (2.4 mg) and Semaglutide (2.4 mg) once a week leads to about 21% weight loss after 32 weeks, showing that the two drugs work well together